Discover the new educational ERN Rare-Liver webinar series launched in November 2020.

In this fourth webinar which took place on 9 February 2021, Dr Karl Heinz Weiss discussed the therapies and emerging treatments for Wilson Disease.

Targeted Audience

  • General practitioners
  • Hepatologists
  • Health care professionals


Karl Heinz Weiss Karl Heinz Weiss is an adult hepatologist and Director of the Dept. of Internal Medicine at Salem Medical Center Heidelberg. His clinical and biochemical research is focused on Wilson disease and copper trafficking. He has been acting as National Coordinating Investigator for several clinical trials in WD and has treated more than 500 WD patients.
Log in to post comments